Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Meloxicam Dispersible Tablets

Approval Number

国药准字H20010108

Company江苏亚邦爱普森药业有限公司

Registration Date

July 9, 2020

Drug Information

Generic Name

美洛昔康分散片

Trade Name

奈邦

Brand Name

奈邦

Dosage Form

片剂

Strength

7.5mg

Drug Type

化学药品

Registration Date

July 9, 2020

Company Information

Applicant Company

Company Name江苏亚邦爱普森药业有限公司

Company Address

盐城市响水县城经济开发区

Manufacturing Company

Company Name

江苏亚邦爱普森药业有限公司;江苏亚邦强生药业有限公司

Company Address

盐城市响水县城经济开发区；常州市金坛区华城路198号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

美洛昔康分散片 - NMPA 批准文号 | MedPath